Editorial
doi: 10.1001/jama.2020.16238.
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes
Affiliations
- PMID: 33107925
- DOI: 10.1001/jama.2020.16238
Item in Clipboard
Editorial
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes
JAMA.
.
No abstract available
Comment on
-
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.JAMA. 2020 Oct 27;324(16):1640-1650. doi: 10.1001/jama.2020.16167. JAMA. 2020. PMID: 33107944 Free PMC article.
Similar articles
-
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945. Circ Cardiovasc Qual Outcomes. 2019. PMID: 30606052
-
Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?Intern Med J. 2017 Nov;47(11):1298-1305. doi: 10.1111/imj.13595. Intern Med J. 2017. PMID: 28857445
-
Efficacy and safety of ticagrelor versus clopidogrel with different dosage in high-risk patients with acute coronary syndrome.Int J Cardiol. 2017 Feb 1;228:275-279. doi: 10.1016/j.ijcard.2016.11.160. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27865197
-
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290. Health Technol Assess. 2015. PMID: 25896573 Free PMC article. Review.
-
Ticagrelor: a review of its use in adults with acute coronary syndromes.Am J Cardiovasc Drugs. 2015 Feb;15(1):51-68. doi: 10.1007/s40256-015-0108-5. Am J Cardiovasc Drugs. 2015. PMID: 25672642 Review.
Cited by
-
Are Bleeding Events Valid as a Surrogate Endpoint for Mortality in Cardiovascular Clinical Trials?JACC Adv. 2023 May 26;2(3):100335. doi: 10.1016/j.jacadv.2023.100335. eCollection 2023 May. JACC Adv. 2023. PMID: 38939574 Free PMC article.
-
Review of the Ticagrelor Trials Evidence Base.J Am Heart Assoc. 2024 Jun 4;13(11):e031606. doi: 10.1161/JAHA.123.031606. Epub 2024 May 28. J Am Heart Assoc. 2024. PMID: 38804216 Free PMC article. Review.
-
An "occlusive thrombosis-on-a-chip" microfluidic device for investigating the effect of anti-thrombotic drugs.Lab Chip. 2021 Oct 26;21(21):4104-4117. doi: 10.1039/d1lc00347j. Lab Chip. 2021. PMID: 34523623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
